Clinical and Hormonal Profiles Correlate With Molecular Characteristics in Patients With 11β-Hydroxylase Deficiency
dc.authorid | yaman, ali/0000-0001-5659-5195 | |
dc.authorid | Kara, Cengiz/0000-0002-8989-560X | |
dc.authorid | Demircioglu, Serap/0000-0002-5172-5402 | |
dc.authorid | GURAN, TULAY/0000-0003-2658-6866 | |
dc.authorid | Catli, Gonul/0000-0002-0488-6377 | |
dc.authorid | Bereket, Abdullah/0000-0002-6584-9043 | |
dc.authorid | UCAKTURK, Seyit Ahmet/0000-0001-8666-4454 | |
dc.contributor.author | Yildiz, Melek | |
dc.contributor.author | Isik, Emregul | |
dc.contributor.author | Abali, Zehra Yavas | |
dc.contributor.author | Keskin, Mehmet | |
dc.contributor.author | Ozbek, Mehmet Nuri | |
dc.contributor.author | Bas, Firdevs | |
dc.contributor.author | Ucakturk, Seyit Ahmet | |
dc.date.accessioned | 2025-02-06T17:58:21Z | |
dc.date.available | 2025-02-06T17:58:21Z | |
dc.date.issued | 2021 | |
dc.department | Altınbaş Üniversitesi | en_US |
dc.description.abstract | Background: Given the rarity of 11 beta-hydroxylase deficiency (11 beta OHD), there is a paucity of data about the differences in clinical and biochemical characteristics of classic (C-11 beta OHD) and nonclassic 11 beta OHD (NC-11 beta OHD). Objective: To characterize a multicenter pediatric cohort with 11 beta OHD. Method: The clinical and biochemical characteristics were retrospectively retrieved. CYP11B1 gene sequencing was performed. Seventeen plasma steroids were quantified by liquid chromatography-mass spectrometry and compared to that of controls. Results: 102 patients (C-11 beta OHD, n = 92; NC-11 beta OHD, n = 10) from 76 families (46,XX; n = 53) had biallelic CYP11B1 mutations (novel 9 out of 30). Five 46,XX patients (10%) were raised as males. Nineteen patients (19%) had initially been misdiagnosed with 21-hydroxylase deficiency. Female adult height was 152 cm [-1.85 SD score (SDS)] and male 160.4 cm (-2.56 SDS).None of the NC-11 beta OHD girls had ambiguous genitalia (C-11 beta OHD 100%), and none of the NC-11 beta OHD patients were hypertensive (C-11 beta OHD 50%). Compared to NC-11 beta OHD, C-11 beta OHD patients were diagnosed earlier (1.33 vs 6.9 years; P< 0.0001), had higher bone age-to-chronological age (P= 0.04) and lower adult height (-2.46 vs -1.32 SDS; P= 0.05). The concentrations of 11-oxygenated androgens and 21-deoxycortisol were low in all patients. The baseline ACTH and stimulated cortisol were normal in NC-11 beta OHD. Baseline cortisol; cortisone; 11-deoxycortisol; 11-deoxycorticosterone and corticosterone concentrations; and 11-deoxycortisol/cortisol, 11-deoxycorticosterone/cortisol, and androstenedione/cortisol ratios were higher in C-11 beta OHD than NC-11 beta OHD patients (P < 0.05). The 11-deoxycortisol/cortisol ratio >2.2, <1.5, and <0.1 had 100% specificity to segregate C-11 beta OHD, NC-11 beta OHD, and control groups. Conclusion: NC-11 beta OHD can escape from clinical attention due to relatively mild clinical presentation. However, steroid profiles enable the diagnosis, differential diagnosis, and subtyping of 11 beta OHD. | en_US |
dc.description.sponsorship | Medical Research Council of Marmara University [SAG-A-120418-0152] | en_US |
dc.description.sponsorship | This work has been supported by the Medical Research Council of Marmara University (Project Grant SAG-A-120418-0152, TG). | en_US |
dc.identifier.doi | 10.1210/clinem/dgab225 | |
dc.identifier.endpage | E3724 | en_US |
dc.identifier.issn | 0021-972X | |
dc.identifier.issn | 1945-7197 | |
dc.identifier.issue | 9 | en_US |
dc.identifier.pmid | 33830237 | |
dc.identifier.scopus | 2-s2.0-85114356813 | |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | E3714 | en_US |
dc.identifier.uri | https://doi.org/10.1210/clinem/dgab225 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12939/5187 | |
dc.identifier.volume | 106 | en_US |
dc.identifier.wos | WOS:000692625700063 | |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Endocrine Soc | en_US |
dc.relation.ispartof | Journal of Clinical Endocrinology & Metabolism | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | KA_WOS_20250206 | |
dc.subject | CYP11B1 | en_US |
dc.subject | congenital adrenal hyperplasia | en_US |
dc.subject | steroid profiling | en_US |
dc.subject | 11-oxygenated androgens | en_US |
dc.subject | adrenal insufficiency | en_US |
dc.subject | androgen excess | en_US |
dc.subject | children | en_US |
dc.title | Clinical and Hormonal Profiles Correlate With Molecular Characteristics in Patients With 11β-Hydroxylase Deficiency | en_US |
dc.type | Article | en_US |